MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 238 filers reported holding MIRATI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,134 | +131.9% | 577 | +92.3% | 0.00% | – |
| Q2 2023 | $10,839 | +23.5% | 300 | +27.1% | 0.00% | – |
| Q1 2023 | $8,774 | -64.5% | 236 | -56.7% | 0.00% | -100.0% |
| Q4 2022 | $24,694 | -73.7% | 545 | -59.6% | 0.00% | -66.7% |
| Q3 2022 | $94,000 | +6.8% | 1,349 | +2.7% | 0.00% | 0.0% |
| Q2 2022 | $88,000 | +214.3% | 1,313 | +288.5% | 0.00% | +200.0% |
| Q1 2022 | $28,000 | +16.7% | 338 | +102.4% | 0.00% | 0.0% |
| Q4 2021 | $24,000 | +380.0% | 167 | +518.5% | 0.00% | – |
| Q3 2021 | $5,000 | +25.0% | 27 | +12.5% | 0.00% | – |
| Q2 2021 | $4,000 | +33.3% | 24 | +33.3% | 0.00% | – |
| Q1 2021 | $3,000 | -57.1% | 18 | -47.1% | 0.00% | – |
| Q4 2020 | $7,000 | +250.0% | 34 | +142.9% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 14 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | – | 14 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |